These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26592721)

  • 1. Evaluation of liposomal nanocarriers loaded with ETB receptor agonist, IRL-1620, using cell-based assays.
    Joshi MD; Oesterling BM; Wu C; Gwizdz N; Pais G; Briyal S; Gulati A
    Neuroscience; 2016 Jan; 312():141-52. PubMed ID: 26592721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of endothelin B receptors by IRL-1620 decreases the progression of Alzheimer's disease.
    Briyal S; Nguyen C; Leonard M; Gulati A
    Neuroscience; 2015 Aug; 301():1-11. PubMed ID: 26022359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats.
    Leonard MG; Gulati A
    Brain Res; 2013 Aug; 1528():28-41. PubMed ID: 23850649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor type B agonist, IRL-1620, prevents beta amyloid (Aβ) induced oxidative stress and cognitive impairment in normal and diabetic rats.
    Briyal S; Shepard C; Gulati A
    Pharmacol Biochem Behav; 2014 May; 120():65-72. PubMed ID: 24561065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats.
    Leonard MG; Briyal S; Gulati A
    Brain Res; 2012 Jun; 1464():14-23. PubMed ID: 22580085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats.
    Leonard MG; Briyal S; Gulati A
    Brain Res; 2011 Oct; 1420():48-58. PubMed ID: 21959172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel neuroregenerative approach using ET(B) receptor agonist, IRL-1620, to treat CNS disorders.
    Gulati A; Hornick MG; Briyal S; Lavhale MS
    Physiol Res; 2018 Jun; 67(Suppl 1):S95-S113. PubMed ID: 29947531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sovateltide (IRL-1620) affects neuronal progenitors and prevents cerebral tissue damage after ischemic stroke.
    Ranjan AK; Briyal S; Khandekar D; Gulati A
    Can J Physiol Pharmacol; 2020 Sep; 98(9):659-666. PubMed ID: 32574518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute pro-inflammatory actions of endothelin-1 in the guinea-pig lung: involvement of ETA and ETB receptors.
    Filep JG; Fournier A; Földes-Filep E
    Br J Pharmacol; 1995 May; 115(2):227-36. PubMed ID: 7670725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an Endothelin B Receptor Agonist on the Tumor Accumulation of Nanocarriers.
    Feng H; Nam LT; Yoshikawa T; Kishimura A; Mori T; Katayama Y
    Biol Pharm Bull; 2020; 43(9):1301-1305. PubMed ID: 32879203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification.
    Cemazar M; Wilson I; Prise VE; Bell KM; Hill SA; Tozer GM
    Br J Cancer; 2005 Jul; 93(1):98-106. PubMed ID: 15970923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique response of human arteries to endothelin B receptor agonist and antagonist.
    Liu JJ; Chen JR; Buxton BF
    Clin Sci (Lond); 1996 Feb; 90(2):91-6. PubMed ID: 8829886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.
    Nambi P; Pullen M; Spielman W
    J Pharmacol Exp Ther; 1994 Jan; 268(1):202-7. PubMed ID: 8301559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated administration of ET(B) receptor agonist, IRL-1620, produces tachyphylaxis only to its hypotensive effect.
    Leonard MG; Gulati A
    Pharmacol Res; 2009 Nov; 60(5):402-10. PubMed ID: 19666119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the ET(B) receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats.
    Rai A; Rajeshkumar NV; Gulati A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1120-2. PubMed ID: 16741060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction of a biphasic bronchospasm by the ETB agonist, IRL 1620, due to thromboxane A2 generation and endothelin-1 release in guinea-pigs.
    Noguchi S; Kashihara Y; Bertrand C
    Br J Pharmacol; 1996 Jul; 118(6):1397-402. PubMed ID: 8832063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of endothelin B receptor agonists on amyloid beta protein (25-35)-induced neuronal cell death.
    Yagami T; Ueda K; Asakura K; Kuroda T; Hata S; Sakaeda T; Kambayashi Y; Fujimoto M
    Brain Res; 2002 Sep; 948(1-2):72-81. PubMed ID: 12383957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065.
    Battistini B; Warner TD; Fournier A; Vane JR
    Br J Pharmacol; 1994 Apr; 111(4):1009-16. PubMed ID: 8032583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats.
    Rajeshkumar NV; Rai A; Gulati A
    Breast Cancer Res Treat; 2005 Dec; 94(3):237-47. PubMed ID: 16244791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endothelin receptor selective antagonists, BQ-123 and BQ-788, on IRL 1620 and endothelin-1 responses of airway and vascular preparations from rats.
    O'Donnell SR; Kay CS
    Pulm Pharmacol; 1995 Feb; 8(1):11-9. PubMed ID: 8535094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.